Lineage Biosciences Overview
- Founded
-
2014
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Lineage Biosciences General Information
Description
Developer of an antibody discovery technology intended to profile antibody responses using sequencing of immunoglobulin genes. The company's technology provides deep analysis of antibodies generated by natural immune responses during infection, autoimmune disease, cancer, immunization and vaccination, enabling the medical industry to develop vaccines and to accelerate antibody discovery.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- 3183 Porter Drive
- Palo Alto, CA 94304
- United States
Lineage Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lineage Biosciences Patents
Lineage Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2012312028-A1 | Detection of isotype profiles as signatures for disease | Inactive | 22-Sep-2011 | 0000000000 | |
| AU-2012312028-A8 | Detection of isotype profiles as signatures for disease | Inactive | 22-Sep-2011 | 0000000000 | |
| CA-2848516-A1 | Detection of isotype profiles as signatures for disease | Active | 22-Sep-2011 | 0000000000 | |
| EP-2758550-B1 | Detection of isotype profiles as signatures for disease | Active | 22-Sep-2011 | 0000000000 | |
| EP-2758550-A1 | Detection of isotype profiles as signatures for disease | Active | 22-Sep-2011 | C12Q1/6869 |